Abstract
The early and accurate discrimination between bacterial and viral causes of acute infections is the key to a better use of antibiotics and will help slow down the fast-growing resistance to commonly used antibiotics. This discrimination is in the vast majority of cases possible to achieve by blood assay of the biomarker human neutrophil lipocalin (HNL), which we showed to be uniquely increased in patients suffering from bacterial infections. In serum, sensitivities and specificities of >90% are achieved in both adults and children. In order to eliminate the need to produce serum, a whole-blood assay with an assay time of <10 min was developed in which blood neutrophils are activated to release HNL. The diagnostic accuracy of this assay also showed sensitivities and specificities of >90% in most infectious diseases and was clearly superior to contemporary assays such as blood neutrophil counts, C-reactive protein, procalcitonin, and expression of CD64 on blood neutrophils. This format lends itself to the development of a point-of-care HNL assay and will be a major step forward to accomplish the goal of accurately diagnosing patients with symptoms of acute infections within 10 min at the emergency room or at the doctor's office.
References
Apr 1, 1995·Scandinavian Journal of Clinical and Laboratory Investigation·S Y XuP Venge
Aug 1, 1994·Scandinavian Journal of Clinical and Laboratory Investigation·S Y XuP Venge
Sep 4, 1999·The Histochemical Journal·A FriedlM N Gould
Dec 10, 1999·Rheumatology·I TorsteinsdóttirP Venge
Dec 22, 1999·The European Respiratory Journal·I EichlerD Y Koller
Nov 4, 2000·Biochimica Et Biophysica Acta·S Xu, P Venge
Jun 8, 2001·Respiratory Medicine·A Ekberg-JanssonC G Löfdahl
Apr 16, 2003·Scandinavian Journal of Infectious Diseases·Anders LannergårdGöran Friman
Jun 11, 2004·Acta Paediatrica·O RudzevicieneR Eidukevicius
Feb 1, 2005·Journal of Clinical Epidemiology·R M HopstakenG J Dinant
Apr 7, 2005·Lancet·Jaya MishraPrasad Devarajan
Sep 29, 2005·Acta Paediatrica·Gustav FjaertoftPer Venge
Oct 6, 2007·Scandinavian Journal of Infectious Diseases·Karlis PauksensPer Venge
Apr 14, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Linjun CaiPer Venge
Sep 11, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Linjun CaiShengyuan Xu
May 23, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Johan MårtenssonPer Venge
Nov 21, 2013·The Lancet Infectious Diseases·Ramanan LaxminarayanOtto Cars
Oct 2, 2014·The New England Journal of Medicine·Carl Nathan, Otto Cars
May 24, 2015·Journal of Immunological Methods·Per VengeKarlis Pauksen
Jul 3, 2015·Clinical and Vaccine Immunology : CVI·Per VengeKarlis Pauksen
Dec 17, 2015·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Vanessa AbellaOreste Gualillo
Feb 24, 2016·Journal of Immunological Methods·Zhang YuPer Venge
Jul 15, 2016·Upsala Journal of Medical Sciences·Dušan JasovskýOtto Cars
May 5, 2017·Clinical and Vaccine Immunology : CVI·Per VengeKarlis Pauksen
Citations
Jul 11, 2019·Stem Cells Translational Medicine·Golnar ShojaatiJames L Funderburgh
Sep 19, 2019·Experimental Animals·Yiwei FengAnzhou Tang
Oct 23, 2019·The Journal of Applied Laboratory Medicine·Per Venge, Shengyuan Xu
Jan 7, 2020·Cellular and Molecular Life Sciences : CMLS·Sayan GhoshDebasish Sinha
Jul 2, 2021·Pediatric Rheumatology Online Journal·Malin BacklundLillemor Berntson